Literature DB >> 13661537

The treatment of pinworm infections in humans (enterobiasis) with pyrvinium chloride and pyrvinium pamoate.

J W BECK, D SAAVEDRA, G J ANTELL, B TEJEIRO.   

Abstract

Entities:  

Keywords:  ANTHELMINTICS/therapeutic use; OXYURIASIS/therapy

Mesh：

Substances：

Year:  1959        PMID： 13661537     DOI： 10.4269/ajtmh.1959.8.349

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


× No keyword cloud information.
  18 in total

1.  Single-dose treatment of oxyuriasis with pyrvinium embonate.

Authors:  A S DESAI
Journal:  Br Med J       Date:  1962-12-15

2.  Pinworm infestation in children: the problem and its treatment.

Authors:  A ROYER; K BERDNIKOFF
Journal:  Can Med Assoc J       Date:  1962-01-13       Impact factor: 8.262

Review 3.  Hepatitis-associated (Australia) antigen: a review.

Authors:  J B Simon
Journal:  Can Med Assoc J       Date:  1971-09-18       Impact factor: 8.262

4.  Synergy between Pyrvinium Pamoate and Azoles against Exophiala dermatitidis.

Authors:  Lujuan Gao; Yi Sun; Chengyan He; Tongxiang Zeng; Ming Li
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

5.  A cell-based high-throughput screening method to directly examine transthyretin amyloid fibril formation at neutral pH.

Authors:  Mitsuharu Ueda; Masamitsu Okada; Mineyuki Mizuguchi; Barbara Kluve-Beckerman; Kyosuke Kanenawa; Aito Isoguchi; Yohei Misumi; Masayoshi Tasaki; Akihiko Ueda; Akinori Kanai; Ryoko Sasaki; Teruaki Masuda; Yasuteru Inoue; Toshiya Nomura; Satoru Shinriki; Tsuyoshi Shuto; Hirofumi Kai; Taro Yamashita; Hirotaka Matsui; Merrill D Benson; Yukio Ando
Journal:  J Biol Chem       Date:  2019-06-05       Impact factor: 5.157

6.  Differential abundance of CK1α provides selectivity for pharmacological CK1α activators to target WNT-dependent tumors.

Authors:  Bin Li; Darren Orton; Leif R Neitzel; Luisana Astudillo; Chen Shen; Jun Long; Xi Chen; Kellye C Kirkbride; Thomas Doundoulakis; Marcy L Guerra; Julia Zaias; Dennis Liang Fei; Jezabel Rodriguez-Blanco; Curtis Thorne; Zhiqiang Wang; Ke Jin; Dao M Nguyen; Laurence R Sands; Floriano Marchetti; Maria T Abreu; Melanie H Cobb; Anthony J Capobianco; Ethan Lee; David J Robbins
Journal:  Sci Signal       Date:  2017-06-27       Impact factor: 8.192

7.  Anthelmintic pyrvinium pamoate blocks Wnt/β-catenin and induces apoptosis in multiple myeloma cells.

Authors:  Fang Xu; Yingjie Zhu; Yuhong Lu; Zhi Yu; Jun Zhong; Yangqiu Li; Jingxuan Pan
Journal:  Oncol Lett       Date:  2018-02-09       Impact factor: 2.967

8.  Efficacy of pyrvinium pamoate against Cryptosporidium parvum infection in vitro and in a neonatal mouse model.

Authors:  Autumn S Downey; Curtis R Chong; Thaddeus K Graczyk; David J Sullivan
Journal:  Antimicrob Agents Chemother       Date:  2008-06-30       Impact factor: 5.191

9.  In vitro activity of pyrvinium pamoate against Entamoeba histolytica and Giardia intestinalis using radiolabelled thymidine incorporation and an SYBR Green I-based fluorescence assay.

Authors:  Autumn S Downey; Thaddeus K Graczyk; David J Sullivan
Journal:  J Antimicrob Chemother       Date:  2009-08-18       Impact factor: 5.790

10.  Non-competitive androgen receptor inhibition in vitro and in vivo.

Authors:  Jeremy O Jones; Eric C Bolton; Yong Huang; Clementine Feau; R Kiplin Guy; Keith R Yamamoto; Byron Hann; Marc I Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-10       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.